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Abstract Dopamine D2 receptor (D2R) signalling has been
shown to modulate seizure-induced hippocampal cell death.
D2R knockout (D2R−/−) mice are more susceptible to kainic
acid (KA)-induced excitotoxicity, displaying cell death in the
CA3 subfield of the hippocampus at KA doses not damaging
in wild-type (WT) animals. Absence of D2R signalling in the
hippocampus leads to activation (dephosphorylation) of gly-
cogen synthase kinase 3β (GSK-3β) after KA (20 mg/kg),
which is not associated with a change in the phosphorylation
of the GSK-3β regulator Akt at the canonical threonine 308
residue. In the present study, we investigated alternative path-
ways responsible for the activation of GSK-3β in the hippo-
campus of the D2R−/− mice 24 h following KA-induced
seizures. Here, we show that phosphorylation of Akt occurs
at serine 473 (Ser473) in the CA3 region ofWT but not D2R−/−
mice following KA. Moreover, the CA1 subregion, which does
not undergo neurodegeneration in either WT or D2R−/− mice,
displays a strong induction of Akt (Ser473) phosphorylation
after KA. Additionally, the vulnerability in the CA3 is not
associated with changes to p38MAPK and Dishevelled activa-
tion, andβ-catenin does not appear to be a downstream target of
the GSK-3β. Thus, we propose that GSK-3β phosphorylation-
mediated hippocampal cell survival may depend on Akt
(Ser473) phosphorylation; loss of D2R-mediated signalling in
the CA3 region of D2R−/−mice leads to reduced Akt (Ser473)
phosphorylation rendering neurons more vulnerable to apo-
ptosis. Further investigation is required to fully elucidate the
GSK-3β targets involved in D2R-dependent response to
excitotoxicity.
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Introduction
Traditionally thought of as an imbalance of excitatory gluta-
mate and inhibitory GABAergic transmission resulting in exci-
totoxicity, seizure-induced cell death has also been shown to be
modulated by dopaminergic signalling (Bozzi and Borrelli
2006; Starr 1996). Mice lacking the dopamine D2 receptor
(D2R−/−mice) (Baik et al. 1995) are more susceptible to kainic
acid (KA)-induced excitotoxicity, displaying neurodegenera-
tion in the CA3 subregion of the hippocampus at KA doses
not epileptogenic for wild-type (WT) mice (Bozzi et al. 2000).
The pathway through which D2Rs modulate seizure-
induced neuronal death in the hippocampus remains to be
elucidated. The canonical pathway of D2R activation in neu-
rons involves G-protein coupled downregulation of adenylate
cyclase and subsequent cAMP downregulation (Bozzi et al.
2011). More recent studies in the striatum, however, suggest a
role for cAMP-independent signalling involving a complex
formed by D2R, protein phosphatase 2A, β-arrestin 2 and Akt
(Bozzi et al. 2011). When activated by dopamine, the D2R
causes the inactivation (dephosphorylation) of Akt at the
threonine 308 residue (Thr308) and subsequent activation
(dephosphorylation) of glycogen synthase kinase 3β (GSK-
3β) (Beaulieu et al. 2011). These studies focus mainly on
signalling in the striatum, with few studies investigating the
cascades downstream of the D2R in the hippocampus. Termi-
nal deoxynucleotidyl transferase dUTP nick end labelling
staining, along with Bax and caspase 3 upregulation, has been
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reported in the CA3 hippocampal subfield of D2R−/− mice
following KA treatment (Bozzi et al. 2000; Tripathi et al.
2010) indicating neuronal apoptosis. This was also associated
with a downregulation (activation) of GSK-3β phosphoryla-
tion at serine 9 (Ser9) residue. Interestingly, these changes in
GSK-3β were not associated with a change in activation of
pAkt (Thr308), suggesting that an alternative pathway is
responsible for the activation of GSK-3β in the hippocampus
of the D2R−/− mice.
Recent research proposes p38 mitogen-activated protein
kinase (p38MAPK) as a potential regulator of GSK-3β activ-
ity, by direct phosphorylation at its C-terminus (Thornton et
al. 2008). Furthermore, GSK-3β is known to be an integral
step in the Wnt signalling pathway. Following activation of
Wnt receptors, Dishevelled (Dvl) is activated thus leading to
GSK-3β inactivation. This, in turn, results in the accumula-
tion of β-catenin in the cytosol, from where it can translocate
to the nucleus and activate the expression of target genes (De
Ferrari and Inestrosa 2000). A recent study also suggests that
GSK-3β phosphorylation can be associated with phosphory-
lation of Akt at serine 473 (Ser473) residue, in the absence of
Akt (Thr308) phosphorylation (Sutton and Rushlow 2011).
Thus, there are a number of potential alternative regulators of
GSK-3β which warrant investigation.
Here, we show that Akt (Ser473) phosphorylation is re-
duced in the D2R−/− CA3 neurons. This might explain the
higher susceptibility to KA-induced damage observed in these
neurons. Additionally, this vulnerability is p38MAPK- and
Dvl-independent. Furthermore, β-catenin does not appear to
be a downstream target of the GSK-3β pathway in D2R−/−
CA3 neurons following KA, suggesting the involvement of
alternative targets.
Materials and Methods
Animals and Seizure Induction
Experiments were performed in accordance with the Euro-
pean Communities Council Directive of 24 November 1986
(86/609/EEC). All possible measures were taken to avoid
animals suffering at each stage of the experiments. All the
mice used in this study were WT and D2R−/− littermates,
obtained from heterozygote intermatings (F2 hybrids,
C57BL/6 × 129/Sv mixed background) (Bozzi et al. 2000;
Tripathi et al. 2010). Seizures were induced in male and
femaleWTandD2R−/− adult mice (20–30 g, 3–5months old)
by intraperitoneal injection of KA (20 mg/kg). Previous stud-
ies from our laboratory showed no differences in susceptibility
to seizures and seizure-induced excitotoxicity between gen-
ders in D2R−/− mice (Bozzi et al. 2000; Tripathi et al. 2010).
Following injection, animals were returned to cages where
seizure severity was assessed at 10-min intervals for up to 2 h,
according to a modified Racine scale (Bozzi et al. 2000;
Tripathi et al. 2010): stage 0, normal behaviour; stage 1,
immobility; stage 2, forelimb and/or tail extension, rigid pos-
ture; stage 3, repetitive movements, head bobbing; stage 4,
rearing and falling; stage 5, continuous rearing and falling;
stage 6, severe whole-body convulsions; stage 7, death.
Saline-injected animals of both genotypes were used as con-
trols. Observers were blind to treatment and genotype of each
animal and scores were assigned based on the maximum stage
reached during the observational period. Twenty-four hours
following KA injection, mice were sacrificed and brains pro-
cessed for immunoblotting and immunohistochemistry as
described below.
Immunoblotting
Brains were immediately cooled for 5 s in liquid nitrogen.
Whole hippocampi were dissected on an ice cold surface
and flash frozen in liquid nitrogen. Proteins were extracted
according to standard protocols established in the laboratory
(Cotrufo et al. 2003) and total protein concentration measured
with Nanodrop spectrophotometer (Thermo Scientific). Total
protein extracts (20 μg; 30 μg for Dvl) were separated on 4–
12 % NuPage Pre-Cast Gels (Invitrogen), transferred to nitro-
cellulose membranes and incubated with the following rabbit
monoclonal antibodies: p38MAPK (1:500), phospho-
p38MAPK (1:500), β-catenin (1:2,000), phosphorylated β-
catenin (1:2,000)(all from Cell Signaling Technologies, MA,
USA); Akt (1:500) and pAkt (Ser473) (1:500) (Abcam, UK);
Dvl (1:10,000), β-tubulin (1:20,000) and GAPDH (1:8,000)
(all from Santa Cruz, CA, USA). Membranes were then
incubated with peroxidase-conjugated goat anti-rabbit sec-
ondary antibodies (1:10,000–20,000) (Santa Cruz, CA,
USA). Protein levels were detected using chemiluminescence
(BioRad) and quantitative densitometry using Image J soft-
ware (http://rsb.info.nih.gov/ij/).β-Tubulin and GAPDHwere
used as a standard for protein quantification. Two to eight
samples per group were analysed.
Immunohistochemistry
Brains were fixed by immersion in 4 % PFA immediately
following sacrifice. Vibratome sections (25 μm, coronal)
were collected in serial order throughout the dorsal hippo-
campus and processed according to standard DAB immu-
nohistochemistry protocol. Briefly, following quenching of
endogenous peroxidases and blocking in 5 % goat serum in
0.1 % PB-T, slices were incubated in primary antibody for
GSK-3β (1:100) pGSK-3β (1:500), Akt (1:500) pAkt
(Ser473)(1:500), p38MAPK (1:80), phospho-p38MAPK
(1:100), β-catenin (1:100) and Dvl (1:50). Bound antibody
was detected by incubation with biotinylated goat anti-rabbit
secondary antibody (1:1,000, Vector Lab, CA, USA) followed
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by incubation with DAB. Images were acquired by using a
bright-field Nikon microscope at ×10 and ×20 primary mag-
nifications. All immunohistochemical analyses were per-
formed on two to five mice per group (one to three sections
per animal per treatment group) with quantitative densitome-
try performed using Image J software. Briefly, images were
converted to greyscale and inverted, mean grey value was
calculated for the CA3 subregion. Results were expressed
relative to saline-treatedWTanimals. Negative controls (slices
incubated only with biotinylated goat anti-rabbit secondary
antibody) did not reveal any detectable signal (data not
shown).
Statistical Analysis
All data are expressed as mean±SEM. Statistical analysis was
performed using the SigmaStat software. Analysis of seizure
scores was performed by applying a two-way repeated meas-
ures ANOVA followed by post hoc Holm–Sidak test. Analysis
of immunoblot and immunohistochemical data was performed
by two-way ANOVA, followed by Bonferroni’s and Holm–
Sidak multiple comparisons post hoc test, respectively.
Results
Increased Sensitivity of D2R−/− Mice to KA-Induced
Seizures
WT and D2R−/− mice were monitored for behavioural
seizures following KA injection. Focal seizures (stage 2)
emerged in both WT (n011) and D2R−/− (n013) animals
within 20 min of KA administration. At 40 min, WT animals
experienced the most severe seizure score (3.1±0.4) which
subsequently subsided. D2R−/− animals, however, experi-
enced more severe seizures (mean score 4.0±0.3 at 60 min)
and maintained significantly higher seizure activity for the
duration of the 120-min observational period (Fig. 1). No
mortality was observed in either group in the 24 h following
KA injection. These results were in agreement with our
previous data (Bozzi et al. 2000; Tripathi et al. 2010).
Effects of KA-Induced Seizures on the p38MAPK Pathway
Previous data from our group showed a marked downregu-
lation of GSK-3β phosphorylation in the hippocampus of
D2R−/− mice following systemic KA injection (Tripathi et
al. 2010). Here, we first investigated the hippocampal
expression of p38MAPK and phosphorylated p38MAPK
in WT and D2R−/− mice after systemic KA injection. Phos-
phorylation by p38MAPK has been proposed as an alterna-
tive mechanism for the inactivation of GSK-3β (Thornton et
al. 2008). Immunoblotting experiments revealed no altered
pattern of p38MAPK and phosphorylated p38MAPK
(p-p38MAPK) levels inWTor D2R−/− saline-treated animals
(n03 per group) (Fig. 2). Similarly, the levels of p38MAPK
and p-p38MAPK were also unaltered 24 h following KA
administration in WT or D2R−/− mice. Quantification of
immunoblotting experiments, as revealed by separate mea-
surement of p38MAPK and p-p38MAPK bands (data not
shown) or by the ratio of p-p38MAPK/p38MAPK, showed
no difference between the four experimental groups (Fig. 2).
Immunohistochemistry experiments (performed on n02–6
mice per group) confirmed these findings, suggesting that
p38MAPK signalling in the hippocampus is not affected by
the induction of seizures.
Effects of KA-Induced Seizures on Wnt Pathway Signalling
GSK-3β has been described to have an important role in the
Wnt pathway, being inactivated following activation of Dvl
(Inestrosa and Arenas 2010). To assess the role of Wnt sig-
nalling in the increased susceptibility to seizure-induced neu-
rodegeneration in the D2R−/− hippocampus, we analysed
whether Dvl levels were altered following KA treatment of
WT and D2R−/− mice. Neither immunoblotting (n05–7 per
group) nor immunohistochemistry (n02–6 per group)
revealed any difference between WT and D2R−/− animals
24 h following saline or KA treatment (Fig. 3). β-Catenin
expression, known to be activated downstream of GSK-3β in
the Wnt pathway, was not altered in our model. Indeed,
immunohistochemistry revealed no alteration in β-catenin or
phosphorylated β-catenin levels in the CA3 of either WT or
D2R−/− animals 24 h following saline or KA treatment (n02–
6 per group). These results were confirmed by immunoblotting
Fig. 1 D2R−/− mice are more susceptible to KA-induced seizures.
Analysis of mean behavioural seizure score at 20-min intervals follow-
ing KA administration (20 mg/kg). D2−/− mice undergo more severe
and sustained seizures (n011–13 per group). *p<0.05 (WT vs D2R−/−,
two-way RM ANOVA followed by Holm–Sidak multiple comparisons
post hoc test)
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analyses for β-catenin and phosphorylated β-catenin (n04 per
group) (Fig. 4). Taken together, these data suggest that the
altered GSK-3β activation following KA-induced seizures is
independent of the Wnt pathway.
Downregulation of pAkt (Ser473) in the CA3
Following KA-Induced Seizures in D2R−/− Mice
Our previous results had shown that hippocampal pAkt
(Thr308) levels were not affected following KA-induced
seizures (Tripathi et al. 2010), suggesting that a non-
canonical pathway may be responsible for the activation of
GSK-3β in the hippocampus of KA-treated D2R−/− mice.
However, recent studies have proposed that D2R-mediated
signalling might affect GSK-3β activity through phosphoryla-
tion of Akt on Ser473 (Sutton and Rushlow 2011). Immuno-
blots performed on protein lysates from whole hippocampi
revealed no change in overall expression of pAkt (Ser473)
24 h following KA administration (n05–8 per group). How-
ever, immunohistochemical analyses performed at the same
Fig. 2 Hippocampal expression of p38MAPK and phosphorylated-
p38MAPK following KA seizures in WT and D2R−/− mice. a Immu-
noblot analysis of phosphorylated p38 MAPK (p-p38MAPK) versus
p38MAPK in the hippocampus from WT and DR2−/− (KO) mice, 24 h
following saline (SAL) and KA treatment (n03 per group). There was
no significant difference in expression levels between any of the
groups. b Representative immunoblots from KA and saline-treated
mice (n01 per lane). GAPDH is included as a loading control. c
Representative photomicrographs (×10 magnification) showing the
CA3 subregion labelled for p38MAPK and p-p38MAPK. Scale bar
250 μm
Fig. 3 Hippocampal expression of Dvl following KA seizures in WT
and D2R−/− mice. a Quantification of immunoblots for Dvl expression
in hippocampi from WT and D2R−/− animals 24 h post-KA-induced
seizures (n05–7 per group). No significant difference in expression
was observed between the groups. b Representative immunoblots of
hippocampal Dvl expression in WT and D2R−/− animals following
saline and KA treatment (n01 per lane). β-Tubulin is included as a
loading control. c DAB immunohistochemistry images (×10 magnifi-
cation) of Dvl expression in the CA3 hippocampal subregion 24 h post-
KA-induced seizures in WT and D2R−/− mice. Scale bar 250 μm.
Abbreviations as in Fig. 2
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time point revealed an increase of pAkt (Ser473) in the CA3
region of WT mice following KA (n02–5 per group) (Fig. 5).
Conversely, the vulnerable CA3 of D2R−/− animals displayed
a downregulation of pAkt (Ser473). These results suggest that
lack of D2R-mediated signalling affects Akt-dependent
modifications not only on Thr308 as shown in the striatum
(Beaulieu et al. 2011) but also on Ser473 in the hippocampus,
which may, in turn, result in an aberrant regulation of GSK-3β
in the CA3 region of D2R−/− mice. Furthermore, the CA1
subregion, which is protected from neurodegeneration in both
WT and D2R−/− mice (Bozzi and Borrelli 2006; Bozzi et al.
2000), maintained strong expression of pAkt (Ser473) follow-
ing KA (Fig. 6) (n02–5 per group). The selective high expres-
sion levels of pAkt (Ser473) in the CA1 might also explain
why we were unable to detect differences between WT and
D2R−/− by western blot analyses. The observed changes in
pAkt (Ser473) levels were independent of any changes in
basal Akt expression in any of the experimental groups
throughout the hippocampal subfields. Our results are in sup-
port of a potential role for Akt (Ser473) phosphorylation on
neuronal survival, which is reduced in the vulnerable CA3 of
the D2R−/− mice.
Fig. 4 Hippocampal expression of β-catenin following KA seizures in
WT and D2R−/− mice. a Quantitative western blot analysis of phos-
phorylated β-catenin (pβ-catenin) versus total β-catenin in the hippo-
campus of WT and D2R−/−mice, 24 h post-KA-induced seizures (n04
per group). No significant difference in expression was observed
between the groups. b Representative immunoblots of pβ-catenin
and β-catenin expression in WT and D2R−/− hippocampi following
saline and KA treatment (n01 per lane). β-Tubulin is included as a
loading control. c DAB immunohistochemistry images (×10 magnifi-
cation) of β-catenin and pβ-catenin expression in the CA3 hippocam-
pal subregion 24 h post-KA-induced seizures in WT and D2R−/−mice.
Scale bar 250 μm. Abbreviations as in Fig. 2
Fig. 5 Hippocampal expression of Akt and pAkt (Ser473) following KA
seizures in WT and D2R−/− mice. a Immunoblot quantification 24 h
following KA-induced seizures reveal no significant difference in expres-
sion of pAkt (Ser473)/Akt following saline or KA treatment in WT or
D2R−/− animals (n05–8 per group). b Representative immunoblots of
hippocampal pAkt (Ser 473) and Akt expression in WT and D2R−/−
animals following saline and KA treatment (n01 per lane). GAPDH is
included as a loading control. c Representative photomicrographs (×20
magnification) of the CA3 subfield, showing upregulation of pAkt
(Ser473) following KA-induced seizures in WT animals in the absence
of a similar upregulation in D2R−/− animals. d Immunohistochemical
quantification reveal upregulation of pAkt (Ser473) in the CA3 of WT
animals which is significantly different to KO animals 24 h following
KA-induced seizures (n02–5 per group). Scale bar 125 μm. Abbrevia-
tions as in Fig. 2. *p<0.05 (WT vs D2R−/−, two-way ANOVA followed
by Holm–Sidak multiple comparisons post hoc test)
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Discussion
The present study shows that loss of D2R signalling in the
CA3 region of D2R−/− mice leads to reduced (Ser473) phos-
phorylation of Akt (a crucial regulator of GSK-3β), thus
rendering neurons more vulnerable to KA-induced damage.
Conversely, other GSK-3β regulatory pathways, such as the
p38MAPK andWnt pathways, do not appear to be involved in
this process.
Dopamine has been shown to play an important role in
the regulation of seizure-induced cell death. While D1-like
dopamine receptors have been shown to have a proconvul-
sant and proapoptotic effect, D2-like dopamine receptors
play the opposite role, ameliorating seizure phenotype and
reducing seizure-induced damage when activated (Bozzi
and Borrelli 2006; Bozzi et al. 2011; Starr 1996). The
canonical D2 receptor signalling pathway acts via Gi/o-coupled
proteins to decrease adenylate cyclase and, in turn, reduce
cAMP production (Callier et al. 2003). However, in the last
decade, the regulation of the Akt/GSK-3β pathway by dopa-
mine has become an area of increasing interest. Activation of
D2R causes the dephosphorylation (inactivation) of pAkt
(Thr308), followed by dephosphorylation (activation) of
GSK-3β (Beaulieu et al. 2005, 2007a). Activity of Akt and
GSK-3β was unaltered following direct modulation of cAMP
levels indicating that this signalling is cAMP-independent
(Beaulieu et al. 2004). Once activated, GSK-3β has been
shown to play a role in neurodegeneration (Gomez-Sintes et
al. 2011). We previously observed an increase of GSK-3β
activity (dephosphorylation) in the D2R−/− hippocampus
24 h after KA-induced seizures (Tripathi et al. 2010). This
change in activity was not accompanied by a change in pAkt
(Thr308) phosphorylation, suggesting that an alternative path-
way may be active in the hippocampus.
The best characterised mechanism of inactivation of
GSK-3β is by Akt, through phosphorylation of the N-
terminus at Ser9 (Cross et al. 1995). However, phosphory-
lation of Akt within the C-terminus at Ser473 has recently
been implicated in the regulation of GSK-3β in D2R sig-
nalling cascade (Sutton and Rushlow 2011). In the present
study, we observed that KA seizures produced a robust
upregulation of pAkt (Ser473) in the WT CA3 but not in
the vulnerable CA3 of D2R−/− mice. In addition, in the
undamaged CA1 subregion of both genotypes, there was
maintenance of high levels of pAkt (Ser473). These data are
in agreement with other studies reporting the expression
levels of pAkt (Ser473) following brain injury. A down-
regulation of pAkt (Ser473) was reported at the impact site
in a model of traumatic brain injury while adjacent areas
which remained undamaged displayed an upregulation of
pAkt (Ser473) (Noshita et al. 2002). Furthermore, models of
global and focal ischemia demonstrate a decrease in pAkt
(Ser473) in the ischemic core along with an increase in pAkt
(Ser473) in undamaged cells (Noshita et al. 2001; Yano et
al. 2001). Transient upregulation of pAkt in the CA1 fol-
lowing global ischemia has also been described in delayed
ischemia-induced cell death (Kawano et al. 2001) and inhi-
bition of pAkt during ischemic preconditioning eliminates
the neuroprotection afforded by the preconditioning stimu-
lus (Yano et al. 2001). This suggests that the observed
response may be dependent on the severity of the stress
stimulus. These data support a role for pAkt (Ser473) in
cell survival following brain insult. In the current model, it
appears that the absence of the D2R pathway in the CA3 of
Fig. 6 No downregulation of pAkt (Ser473) in the CA1 subfield follow-
ing KA seizures in WT and D2R−/− mice. a Representative DAB
immunohistochemistry images (×10 magnification) displaying mainte-
nance of pAkt (Ser473) levels 24 h post-KA-induced seizures in the CA1
subregion in both WT and D2R−/− mice. b Immunohistochemical
quantification 24 h following KA-induced seizures reveal no significant
difference in expression of pAkt (Ser473) following saline or KA treat-
ment in WT or D2R−/− animals (n02–5 per group). Scale bar 250 μm.
Abbreviations as in Fig. 2
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D2R−/−mice prevents pAkt (Ser473) upregulation in response
to KA challenge; this could be consistent with the enhanced
vulnerability of CA3 pyramidal neurons to excitotoxic dam-
age. Since, at low KA doses (20 mg/kg), WT mice with a
C57Bl/6-derived genetic background are resistant to seizure-
induced damage (Bozzi et al. 2000; Schauwecker and Steward
1997), the absence or reduction of pAkt (Ser473) signalling
may promote the more vulnerable state observed in D2R−/−
mice. Conversely, increased levels of level of pAKT in D2R−/−
mice might have a protective effect. Increased levels of pAkt
have been detected in the striatum (Beaulieu et al. 2007b) but
not in the hippocampus (this study, Fig. 5; Tripathi et al. 2010)
under basal conditions. Thus, it would be interesting to inves-
tigate the neuroprotective effect of pharmacological upregula-
tion of pAkt, obtained for example by neurotrophin receptor
activation (Iwakura et al. 2008)
Contrary to what is described in this study, dephosphor-
ylation of pAkt (Ser473) has been reported 24 h following
KA (30 mg/kg) in whole hippocampal protein extracts
(Crespo-Biel et al. 2007). This may be explained by the
different pattern of damage in the two models. Crespo-Biel
et al. describe a diffuse hippocampal damage including the
CA3, DG and CA1 [Crespo-Biel et al. 2007], while in the
current model only a small subset of CA3 neurons are
vulnerable to the insult (Bozzi and Borrelli 2006). Some
evidence suggests phosphorylation of Akt can occur more
rapidly after KA treatment: an acute upregulation of pAkt
(Ser473) has been observed 15 min following systemic KA
(30 mg/kg) administration in vivo, which returns to control
levels after 4 h. This was associated with a concomitant
upregulation of pGSK-3β (Thr308) at 15 min, which also
returned to control levels after 4 h (Rojo et al. 2008).
Accordingly, it may be of interest in the current model to
examine earlier time points, where an even more robust
alteration in pAkt (Ser473) activity might be observed.
We exclude that the downregulation of pAkt (Ser473)
detected in the CA3 subfield of D2R−/− mice is due to a
massive cell death in this area. First, we previously showed
that the KA dose used in this study (20 mg/kg) induces cell
death only in a very small subset of CA3 cells in D2R−/−mice,
and this degeneration is detectable only after 5 days from KA
administration (Bozzi et al. 2000). Indeed, cresyl violet stain-
ing of hippocampal sections from D2R−/− 24 h following KA
administration revealed a very limited cell damage in the CA3
area (data not shown). Second, our previous results showed
that hippocampal pAkt (Thr308) levels were not affected fol-
lowing KA-induced seizures (Tripathi et al. 2010), suggesting
that the downregulation of pAkt (Ser473) is specific and not
related to cell loss.
p38MAPK is part of a signalling cascade that has been
implicated in the neuronal death associated with KA-induced
seizures (Herlaar and Brown 1999; Park et al. 2008), with
expression peaking between 1 and 4 days post-seizures
(Kim et al. 2004). p38MAPK has also been implicated as an
alternative regulator of GSK-3β phosphorylation (Thornton et
al. 2008). The absence of any alteration in expression and
phosphorylation of p38MAPK suggests that the GSK-3β
activation observed in KA-treated D2R−/− mice (Tripathi et
al. 2010) is p38MAPK-independent. Previous studies have
shown phosphorylation of p38MAPK peaks 1 day following
KA (Kim et al. 2004), which is the same time analysed in the
current experiments. Again, this may result from the milder
insult observed in the present study (CA3 damage only in
D2R−/− mice), while the induction of p38MAPK activity is
associated with severe damage in the CA3 andmild damage in
the CA1 (Kim et al. 2004).
Finally, we investigated two key members of the Wnt
signalling pathway to reflect potential activation of GSK-3β
and cell death seen in KA-treated D2R−/− mice. The Wnt
pathway has been identified as one of the key regulators of
GSK-3β activity in a number of pathological conditions
(Inestrosa and Arenas 2010) and may play a role in KA
seizure-induced damage. Following activation of the cell
surface receptor Frizzled, Dvl is activated and leads to the
activation of a complex including Axin, APC and GSK-3.
Under basal conditions, this complex acts to phosphorylate
β-catenin, which in turn leads to its degradation. However,
when activated, the complex prevents β-catenin degradation
allowing it to accumulate in the cytosol, translocate to the
nucleus and promote the expression of target genes. In the
current study however, no change in total Dvl expression
was observed. Recent studies suggest that D2R could
regulate Akt activity specifically by Dvl-3 and indepen-
dent of Dvl-1 and Dvl-2 (Sutton and Rushlow 2011).
Further investigation into the specific activities of the
different Dvl homologs may provide clarification on any
involvement of Dvl.
Increased total and dephosphorylated (active) β-catenin
have been shown to result in death of dopaminergic neurons
(Rawal et al. 2009), with alterations in β-catenin phosphor-
ylation being linked to neurodegeneration in models of
Alzheimer’s disease (Lucas et al. 2001). The role of β-
catenin in seizure-induced cell death remains poorly investi-
gated. One study reported the induction of β-catenin in the
hippocampus of rats which underwent massive brain damage
after systemic KA, while rats with no damage showed no
change in β-catenin expression (Busceti et al. 2007).
Once again, the absence of β-catenin regulation in the
KA-treated D2R−/− mice may be a result of the CA3-
restricted hippocampal damage experienced by these animals
(Bozzi et al. 2000).
Further experiments are required to fully elucidate the role
of Akt /GSK-3β signalling to CA3 neuronal death in the
current model. Recent advances in animal models have proved
an important tool in investigating GSK-3β deregulation in
neuronal death (for review, see Gomez-Sintes et al. 2011).
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Employment of mouse models involving downregulation,
upregulation or modulation of GSK-3b could demonstrate a
functional role for GSK-3β in the neuronal death observed in
the current model.
We propose that the neurodegeneration observed in the
CA3 of D2R−/−mice following a low dose of KA may result
from the reduced neuroprotective response normally afforded
by upregulation of pAkt (Ser473), and this effect is indepen-
dent of p38MAPK and Dvl activity. In addition, β-catenin
expression is not altered in the hippocampus of KA-treated
D2R−/− mice, suggesting further investigation is required to
fully elucidate the targets of GSK-3β (such as Tau; De Ferrari
and Inestrosa 2000; Hartigan and Johnson 1999) downstream
of D2R that may be involved in dopamine-dependent response
to excitotoxicity.
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